FDA Person
FDAAnn B. Borromeo
View detailed information about Ann B. Borromeo, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 105 inspections of 100 companies, 2016–2025.
Inspections (105)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 10, 2025 | Deirdre O. Hooper, M.D. | VAI | Product Evaluation: Medical Devices | #1281081 |
| July 18, 2025 | Otsuka Pharmaceutical Development & Commercialization, Inc | Not classified | #1273580 | |
| June 27, 2025 | Nicolaas C. Geurs, DDS | Not classified | #1275183 | |
| June 5, 2025 | W Timothy Garvey MD | NAI | Bioresearch Monitoring | #1272438 |
| May 14, 2025 | Southern Research Institute | Not classified | #1271103 | |
| April 17, 2025 | Asefa J. Mekonnen, MD | Not classified | #1267786 | |
| March 27, 2025 | Samuel M. Alexander, M.D. | Not classified | #1266325 | |
| March 7, 2025 | David M. Huffman, M.D. | Not classified | #1263978 | |
| March 7, 2025 | David M. Hyman, M.D. | NAI | Bioresearch Monitoring | #1263978 |
| February 14, 2025 | Maxim V. Mokin, MD, PhD | NAI | Bioresearch Monitoring | #1262004 |
| January 31, 2025 | Courtney A. Schreiber, M.D. | NAI | Bioresearch Monitoring | #1260763 |
| January 15, 2025 | Key Therapeutics, LLC | Not classified | #1259586 | |
| January 15, 2025 | Burke Therapeutics, LLC | NAI | Bioresearch Monitoring | #1259586 |
| December 4, 2024 | Covenant Health System IRB | Not classified | #1256498 | |
| November 6, 2024 | Harry Earl Studdard, MD | Not classified | #1255107 | |
| October 17, 2024 | USAntibiotics LLC | NAI | Bioresearch Monitoring | #1254251 |
| September 26, 2024 | QPS, LLC | NAI | Bioresearch Monitoring | #1252806 |
| September 6, 2024 | Samuel A. Mickelson, MD | Not classified | #1249377 | |
| August 9, 2024 | Matthew G. Davis, M.D. | NAI | Bioresearch Monitoring | #1247057 |
| July 16, 2024 | East Tennessee State University/Veterans Affairs IRB | NAI | Bioresearch Monitoring | #1245094 |
Documents (16)
- EIR · John P Devincenzo MD · March 16, 2021
- EIR · Craig R Reinemeyer, DVM PhD · February 16, 2021
- 483 · Han C. Phan, M.D. · April 5, 2024
- 483 · Angela D. Ritter, M.D. · August 17, 2023
- 483 · Paul A. Goepfert, MD. · November 20, 2020
- 483 · East Tennessee Clinical Research, Inc · May 26, 2023
- EIR · Han C. Phan, M.D. · April 5, 2024
- EIR · William E. Kirby, MD · August 4, 2016
- EIR · East Tennessee Clinical Research, Inc · May 29, 2012
- 483 · Deirdre O. Hooper, M.D. · September 10, 2025
- 483 · Jan L. Brandes, M.D. · October 18, 2019
- 483 · William E. Kirby, MD · January 17, 2019
- 483 · East Tennessee Clinical Research, Inc · October 21, 2014
- 483 · Ashwani K. Singal, M.D. · September 28, 2018
- 483 · Vanderbilt University Medical Center RDRC · April 1, 2015
- 483 · Melanie M Hoppers, MD · December 15, 2022
Frequently inspected with (10)
Fabian N. Chaparro-rodriguez
7 shared
Kellie R. Riggs
investigator
5 shared
Matthew R. Coleman
3 shared
Christopher M. Jeffers
2 shared
Koffi A. Amegadje
issuing_officer
2 shared
Matthew R. Mcnew
2 shared
Ana C. Lazo
issuing_officer
1 shared
Bernardica T. Sculac Stern
1 shared
Cheryl A. Grandinetti
investigator
1 shared
Delisa R. Davis
1 shared
Person Information
Name
Ann B. Borromeo
Title
investigator
Role
COMPANY REP
ID: ca03a531-043c-4195-b100-a8a0fc763159
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.